Metformin vs MemeCore

MemeCore (M) is 233367.3× the size of Metformin (MET) by market capitalisation. Over the past 30 days, MET is ahead by 4.9 percentage points (MET -22.3% against M -27.3%). Their daily returns move closely together (correlation 0.64 across 23 shared trading days). MET has been the more volatile of the two, at 198% annualised against M's 108%.

Correlation: 0.64
Size ratio: 1 : 233367.3
Ahead over 30 days: MET

MetforminMET

$7.810e-6

24h: —
Market cap: $7,800
Volume 24h: —
Volatility (ann.): 198%

MemeCoreM

$0.793384

24h: -6.25%
Market cap: $1.82B
Volume 24h: $723,643
Volatility (ann.): 108%

MET 0.0%Share of the two combined market caps100.0% M

Performance

METM

7 days-8.04%-19.79%MET
30 days-22.35%-27.25%MET

Correlation

0.64over 23 shared trading days

−1 opposite0 unrelated+1 in step

7d: insufficient data30d: insufficient data90d: insufficient data1y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

Metric	MET	M
Max drawdown (400d)	-32.4%	-41.1%
Risk-adjusted return (90d)	-0.11	-0.25

Relative strength over 90 days: M outperformed MET by 7.6% — measured on the MET/M ratio, so it holds regardless of market direction.

Metformin →MemeCore →